Is that really ADHD? Why flawed trials may be misleading millions
Science Daily: Pharmacology News
JULY 1, 2025
Researchers reviewing nearly 300 top-tier ADHD drug trials found that half skipped the rigorous, expert-led evaluations needed to rule out other conditions like depression or schizophrenia.
Let's personalize your content